Objective: To report the immediate and midterm results of transcatheter closure of
perimembranous ventricular septal defect (PmVSD) using the Amplatzer membranous VSD …

Objectives To describe the initial world experience and mid‐term follow‐up of
perimembranous ventricular septal defect (pmVSD) closure with a newly designed occluder …

The surgical closure of membranous ventricular septal defects (VSDs) is associated with
morbidity and low mortality. Six patients with VSDs located in the membranous part of the …

Objectives: This phase I study attempted to report the initial safety and efficacy results of
transcatheter closure of perimembranous ventricular septal defects (PmVSDs) using the new …

This study reports the midterm results and experience of a single center of transcatheter
closure of perimembranous ventricular septal defect (VSD) with Amplatzer membranous …

Percutaneous closure of perimembranous ventricular septal defects (VSDs) has been
feasible, safe, and effective with the new Amplatzer membranous septal occluder. We report …

OBJECTIVE: The development of the Amplatzer Membranous VSD Occluder (AGA Medical
Corp, Plymouth, Minn) for closure of the perimembranous ventricular septal defect has …

Aims The aim of this study was to evaluate the safety and efficacy of transcatheter closure for
perimembranous ventricular septal defect (pmVSD) and its long-term results. The most …

This multicenter study assessed the efficacy and safety of transcatheter closure of
perimembranous ventricular septal defect (VSD) using a modified double-disk occluder. In 5 …

Objectives: We sought to analyze safety, efficacy, and follow-up results of percutaneous
closure of perimembranous ventricular septal defects (pmVSD). Background: Results of …